Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monoclonal antibody
Biotech
Genmab axes anti-CD38 antibody after losing J&J support
J&J is dropping a partnership with Genmab centered around a CD38 monoclonal antibody, prompting the Danish company to discontinue the program.
Gabrielle Masson
Mar 10, 2025 2:13pm
Windward generates $200M with Novo Holdings, OrbiMed in tow
Jan 10, 2025 10:02am
Omeros stock up after data analysis spurs BLA resubmission plan
Dec 19, 2024 10:54am
Roivant’s midstage asset fails to show benefit in lung disease
Dec 3, 2024 10:32am
Jade pockets Aerovate in reverse merger
Oct 31, 2024 3:03pm
Awaiting regulator verdict, Innovent posts latest psoriasis win
Oct 29, 2024 9:50am
